You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Dow
Boehringer Ingelheim
Johnson and Johnson
Express Scripts
Colorcon
Merck

Last Updated: February 28, 2021

DrugPatentWatch Database Preview

Immunoglobulin g - Biologic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Recent Clinical Trials for immunoglobulin g

Identify potential brand extensions & biosimilar entrants

SponsorPhase
Fondazione SchenaPhase 4
University of BariPhase 4
SobiPhase 3

See all immunoglobulin g clinical trials

Patent Text Search: US Patents for immunoglobulin g

These patents were identified by searching patent claims

Supplementary Protection Certificates for immunoglobulin g

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2018 00018 Denmark   Start Trial PRODUCT NAME: PADELIPORFIN DIPOTASSIUM SALT; REG. NO/DATE: EU/1/17/1228 20171114
2018 00018 Denmark   Start Trial PRODUCT NAME: PADELIPORFIN DIPOTASSIUM SALT; REG. NO/DATE: EU/1/17/1228 20171114
C0002 France   Start Trial PRODUCT NAME: SEL DIPOTASSIQUE DE PADELIPORFINE; REGISTRATION NO/DATE: EU/1/17/1228 20171114
C/GB10/043 United Kingdom   Start Trial PRODUCT NAME: DENOSUMAB, IMMUNOGLOBULIN G2, ANTI-(HUMAN TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 11 (HUMAN OSTEOCLAST DIFFERENTIATION FACTOR))(HUMAN MONOCLONAL AMG 162 HEAVY CHAIN), DISULPHIDE WITH HUMAN MONOCLONAL AMG 162 LIGHT CHAIN, DIMER.; REGISTERED: UK EU/1/10/618/001 20100526; UK EU/1/10/618/002 20100526; UK EU/1/10/618/003 20100526; UK EU/1/10/618/004 20100526
01830022 Spain   Start Trial PRODUCT NAME: PADELIPORFINA; NATIONAL AUTHORISATION NUMBER: EU/1/17/1228; DATE OF AUTHORISATION: 20171110; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/17/1228; DATE OF FIRST AUTHORISATION IN EEA: 20171110
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Merck
McKesson
AstraZeneca
Harvard Business School
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.